ARCHIVES

Patenting the Gene: Cancer Advocates and Industry Diverge on Myriad Ruling

This article is from The Cancer Letter archive.

Vol. 39 No. 24 | June 14, 2013

Download PDF Visit The Full Archive

Related Articles

Senate Committee Approves Additional $400 Million For NCI, $275 Million For FDA.

May 16, 2008

PFS Is A Benefit “In The Right Context,” Pazdur Says In Q&A On Avastin Approval.

February 29, 2008

Shared Decisionmaking Called For In PSA Screening For Ages 55-69

May 31, 2013

In Brief: Radiation Therapy Pioneer Juan Del Regato Dead At 90

July 16, 1999

Novel Antifungal Agent Highly Active Against Esophageal Candidiasis

October 31, 2003

Attempt To Push NCI To Establish Diagnostic Coordinating Group Fails

July 5, 1974